SPECIAL NOTICE
36 -- Xofigo Radium Ra-223 Dichloride injections | EDA: 1/5/2021 | Status: Creating FAR8 Brand Name Justification (11/30/20 alt). Preparing Market Research Report (11/27/20 alt).
- Notice Date
- 12/11/2020 10:04:54 AM
- Notice Type
- Special Notice
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- 244-NETWORK CONTRACT OFFICE 4 (36C244) PITTSBURGH PA 15215 USA
- ZIP Code
- 15215
- Solicitation Number
- 36C24421Q0136
- Archive Date
- 12/21/2020
- Point of Contact
- andrew.taylor3@va.gov, Andrew Taylor, Phone: (724) 285-2533
- E-Mail Address
-
Andrew.Taylor3@va.gov
(Andrew.Taylor3@va.gov)
- Awardee
- null
- Description
- A firm-fixed price, sole source purchase order for Xofigo Injection 6 ML/vial (Radium Ra-223 Dichloride injection 6ml/vial, National Drug Code: 50419-0208-01), will be awarded directly to Cardinal Health 414. Bayer HealthCare Pharmaceuticals, Inc. is the manufacture and Cardinal Health 414, LLC. is the only authorized distributor of Xofigo.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/537695cafa4544069489fd8951ebef3c/view)
- Record
- SN05872040-F 20201213/201211230139 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |